NCT01477671
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +10 more
- Locations
-
- Kalyani, West Bengali, India
- Bangalore, India
- Hyderabad, India
- New Delhi, India
Clinical trial condition
Severe Dengue
Explore clinical trials studying Severe Dengue. Study availability and eligibility vary by location and protocol.
59 public trials
3 recruiting studies
Severe Dengue trial results
NCT00468858
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +11 more
- Locations
-
- San Juan Batista Medical School Caguas, Puerto Rico
- Private Practice Carolina, Puerto Rico
- St Luke's Memorial Hospital Ponce, Puerto Rico
- Caparra Internal Medicine Research Center Rio Grande, Puerto Rico
NCT01702857
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +9 more
- Locations
-
- Clinical Research Center, 1st Floor University Hospital San Juan, Puerto Rico
Completed
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
NCT01436422
- Conditions
- Arbovirus Infections, Dengue, Flaviviridae Infections, +8 more
- Locations
-
- Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States
- Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC) Burlington, Vermont, United States
- University of Vermont Vaccine Testing Center Burlington, Vermont, United States
Completed
Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults
NCT00740155
- Conditions
- Arbovirus Infections, Dengue, Dengue Diseases, +12 more
- Locations
-
- Tlalpan, Mexico
- Valle de Chalco, Mexico
Completed
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults
NCT00831012
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +9 more
- Locations
-
- Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States
NCT01064141
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +10 more
- Locations
-
- San Pablo, Philippines
Completed
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults
NCT00270699
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +9 more
- Locations
-
- Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States
NCT01073306
- Conditions
- Arbovirus Infections, Dengue, Dengue Virus, +9 more
- Locations
-
- Johns Hopkins Project SAVE, Center for Immunization Research Washington D.C., District of Columbia, United States
NCT00919178
- Conditions
- Arbovirus Infections, Dengue, Dengue Hemorrhagic Fever, +10 more
- Locations
-
- Center for Immunization Research, Johns Hopkins School of Public Health Baltimore, Maryland, United States
- University of Vermont Vaccine Testing Center Burlington, Vermont, United States